Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 2,420 | 3,284 | 3,041 | 7,728 | 0 |
| Cost of Goods | 1,399 | 1,791 | 1,625 | 1,190 | N/A |
| Gross Profit | 1,021 | 1,493 | 1,416 | N/A | N/A |
| Operating Expenses | 82,027 | 83,690 | 70,283 | -1,000 | 0 |
| Operating Income | -80,607 | -81,406 | -68,242 | -61,167 | N/A |
| Interest Expense | 297 | 313 | 325 | 320 | 0 |
| Other Income | 460 | -2,661 | 119 | 1,621 | 0 |
| Pre-tax Income | -80,444 | -84,380 | -68,448 | -59,866 | 0 |
| Income Tax | -565 | -369 | 1,013 | 3,433 | N/A |
| Net Income Continuous | -79,879 | -84,011 | -69,461 | N/A | N/A |
| Net Income | $-79,879 | $-84,011 | $-69,461 | $N/A | $N/A |
| EPS Basic Total Ops | -2.76 | -3.00 | -2.40 | -2.44 | N/A |
| EPS Basic Continuous Ops | -2.81 | -2.96 | -2.45 | N/A | N/A |
| EPS Diluted Total Ops | -2.76 | -3.00 | -2.40 | -2.44 | N/A |
| EPS Diluted Continuous Ops | -2.81 | -2.96 | -2.45 | N/A | N/A |
| EBITDA(a) | $-78,200 | $-78,993 | $-65,935 | $7,728 | $N/A |